Calithera Biosciences seeks $80 million in IPO
August 25, 2014 at 17:58 PM EDT
Cancer drug developer Calithera Biosciences Inc. is seeking $80 million through an initial public offering, the company said in a Securities and Exchange Commission filing Monday...
